8-KRegulation FD

DEXCOM INC 8-K Report, Regulation FD Disclosure (Apr 9, 2007)

Filed April 9, 2007For Securities:DXCM

Summary

This Form 8-K filing by DexCom, Inc. (DXCM) on April 9, 2007, announces a significant development regarding the Centers for Medicare and Medicaid Services (CMS) Healthcare Common Procedure Coding System (HCPCS). The CMS HCPCS Workgroup issued a preliminary positive decision to establish specific HCPCS codes for DexCom's continuous glucose monitoring (CGM) devices. This decision is a crucial step towards potential reimbursement for DexCom's products by Medicare and other payers that follow CMS coding. While this preliminary decision is encouraging, investors should note that it is not final and is subject to change. A public meeting is scheduled for May 1, 2007, to gather further input. The final decisions are anticipated to be published in the Federal Register in late October or early November 2007, with potential effectiveness on January 1, 2008. This development could significantly impact the accessibility and adoption of DexCom's CGM technology by expanding its coverage and reimbursement landscape.

Key Highlights

  • 1DexCom, Inc. received a preliminary positive decision from the CMS HCPCS Workgroup to establish specific HCPCS codes for its continuous glucose monitoring (CGM) devices.
  • 2This preliminary decision represents a significant step towards potential reimbursement for DexCom's CGM technology from Medicare and other payers.
  • 3A public meeting is scheduled for May 1, 2007, to allow for public input on the preliminary decision.
  • 4The preliminary decision is not final and is subject to change by CMS.
  • 5Final HCPCS coding decisions are expected to be published in the Federal Register in late October or early November 2007.
  • 6If finalized, the HCPCS codes for CGM devices would become effective on January 1, 2008.

Frequently Asked Questions

The preliminary positive decision from the CMS HCPCS Workgroup to establish specific codes for DexCom's continuous glucose monitoring (CGM) devices is highly significant. It indicates that CMS is moving towards recognizing and coding these devices, which is a critical step for potential reimbursement from Medicare and other payers. This could greatly expand market access and adoption of DexCom's technology.

No, this preliminary decision is not final and is subject to change. There will be a public meeting on May 1, 2007, to gather additional input. Final decisions are anticipated to be published in the Federal Register in late October or early November 2007.

If the HCPCS codes are finalized as expected, they would become effective on January 1, 2008.

HCPCS (Healthcare Common Procedure Coding System) codes are used by healthcare providers and suppliers to bill Medicare and other health insurance programs for services and supplies. For investors, the establishment of specific HCPCS codes for DexCom's CGM devices is crucial because it directly impacts the potential for these devices to be covered and reimbursed by insurance, which is a key driver of sales and revenue growth for medical device companies.